Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle- stimulating hormone step-down regimen

Fertility and Sterility

Volumn 70, Issue 2, 1998, Pages 234-239

  Simón, Carlos ^a   Garcia Velasco, Juan J ^b   Valbuena, Diana ^b   Peinado, Jose A ^b   Moreno, Carlos ^b   Remohí, José ^b   Pellicer, Antonio ^b  

^a INSTITUTO VALENCIANO DE INFERTILIDAD   (Spain)

^b NONE

Author keywords

Estradiol; High responders; Step down

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; NEO FERTINORM; PROGEFFIK; PROGESTERONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HORMONAL THERAPY; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; NIDATION; OVULATION INDUCTION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; CYTOPLASM; DRUG ADMINISTRATION SCHEDULE; EMBRYONIC DEVELOPMENT; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HUMANS; MALE; MICROINJECTIONS; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; PROSPECTIVE STUDIES; SPERM-OVUM INTERACTIONS; UTERUS;

EID: 0032146466     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(98)00140-X     Document Type: Article

References (24)

1. 1. Assisted reproductive technology in the United States and Canada: 1994 results generated from the American Society for Reproductive Medicine/Assisted Reproductive Technology Registry. Fertil Steril 1996;66:697-705.
2. 2. Conaghan J, Hardy K, Handyside AH, Winston RML, Leese HJ. Selection criteria for human embryo transfer: a comparison of pyruvate uptake and morphology. J Assist Reprod Genet 1993;10:21-30.
3. 3. Paulson RJ, Sauer MV, Lobo RA. Embryo implantation after human in vitro fertilization: importance of endometrial receptivity. Fertil Steril 1990;53:870-4.
4. 4. Garcia JE, Acosta AA, Hsiu JG, Jones HW. Advanced endometrial maturation after ovulation induction with human menopausal gonadotrophin/human chorionic gonadotrophin for in vitro fertilization. Fertil Steril 1984;41:31-7.
5. 5. Bladford AJ, Najmabadi S, Paulson RJ. Ultrastructural characteristics of the luteal phase endometrium in donors undergoing controlled ovarian hyperstimulation. Fertil Steril 1997;67:625-30.
6. 6. Simón C, Mercader A, Frances A, Gimeno MJ, Polan ML, Remohí J, et al. Hormonal regulation of serum and endometrial IL-1α, IL-1β, and IL-1ra: IL-1 endometrial microenvironment of the human embryo at the apposition phase under physiological and supraphysiological steroid level conditions. J Reprod Immunol 1996;31:165-84.
7. 7. Pellicer A, Ruiz A, Castellví RM, Calatayud C, Ruiz M, Tarín JJ, et al. Is the retrieval of high numbers of oocytes desirable in patients treated with gonadotrophin-releasing hormone analogues (GnRHa) and gonadotrophins? Hum Reprod 1989;4:536-40.
8. 8. Tarín JJ, Pellicer A. Consequences of high ovarian response to gonadotrophins: a cytogenetic analysis of unfertilized human oocytes. Fertil Steril 1990;54:665-70.
9. 9. Simón C, Cano F, Valbuena D, Remohí J, Pellicer A. Clinical evidence for a detrimental effect on uterine receptivity of high serum estradiol levels in high and normal responder patients. Hum Reprod 1995;10:2432-7.
10. 10. Pellicer A, Valbuena D, Cano F, Remohí J, Simón, C. Lower implantation rates in high responders: evidence for an altered endocrine milieu during the preimplantation period. Fertil Steril 1996;65:1190-5.
11. 11. Testart J, Belaisch-Allart J, Forman R, Gazengel A, Hazout A, Strubb N, et al. Influence of different stimulation treatments on oocyte characteristics and in vitro fertilizing ability. Hum Reprod 1989;4:192-7.
12. 12. Toner J, Brzyski R, Oehninger S, Veeck L, Simonetti S, Muasher S. Combined impact of the number of preovulatory oocytes and cryopreservation on IVF outcome. Hum Reprod 1991;6:284-9.
13. 13. Chenette PE, Sauer MV, Paulson RJ. Very high serum estradiol levels are not detrimental to clinical outcome of in vitro fertilization. Fertil Steril 1990;54:858-63.
14. 14. Tarín JJ, Sampaio MC, Calatayud C, Castellví RM, Bonilla-Musoles F, Pellicer A. Relativity of the concept "high responder to gonadotrophins." Hum Reprod 1992;7:19-22.
15. 15. Fauser BCJM, Donderwinkel P, School DC. The step-down principle in gonadotrophin treatment and the role of GnRH analogues. Baillieres Clin Obstet Gynaecol 1993:7:309-30.
16. 16. Possum GT, Davidson A, Paulson RJ. Ovarian hyperstimulation inhibits embryo implantation in the mouse. J In Vitro Fertil Embryo Transfer 1989;6:7-10.
17. 17. Smith MG. On the interruption of pregnancy in the rat by injection of ovarian follicular extract. Johns Hopkins Hospital Bulletin 1926;39: 203-14.
18. 18. McLean-Morris J, Van Wagenen G. Interception: the use of the preovulatory estrogens to prevent implantation. Am J Obstet Gynecol 1973;115:101-6.
19. 19. Gidley-Baird AA, O'Neil C, Sinosich MJ, Porter RN, Pike IL, Saunders DM. Failure of implantation in human in vitro fertilization and embryo transfer patients: the effects of altered progestrone/estrogen ratios in humans and mice. Fertil Steril 1986;45:69-75.
20. 20. Ben Rafael Z, Strauss JF, Mastroianni L, Flickinger GL. Differences in ovarian stimulation in HMG stimulated women may be related to FSH accumulation. Fertil Steril 1986;46:586-92.
21. 21. Hillier SG. Regulation of follicle estrogen biosynthesis: a survey of current concepts. J Endocrinol 1981;89:3-18.
22. 22. Brown JB. Pituitary control of ovarian function: concepts derived from gonadotrophin therapy. Aus N Z J Med 1978;18:47-54.
23. 23. Mannaerts B, Shoham Z, Schoot B, Bouchard P, Harlin J, Fauser B, et al. Single-dose pharmacokinetics and pharmacodynamics of recombinant human FSH (ORG 32489*) in gonadotropin-deficient volunteers. Fertil Steril 1993;59:108-14.
24. 24. Hadi FH, Chantler E, Anderson E, Nicholson R, McClelland RA, Seif MW. Ovulation induction and endometrial steroid receptors. Hum Reprod 1994;9:2405-10.